PDS Biotech Reports An Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
Synopsis: PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional immunotherapeutic products, today announced…